C51H35N5OPt-2 — CID 166053020
9-[4-(azetidin-1-yl)-2-pyridinyl]-2-[3-[3-[2,6-bis(2,3,4,5,6-pentadeuteriophenyl)phenyl]-2H-benzimidazol-3-ium-2-id-1-yl]benzene-2-id-1-yl]oxy-1H-carbazol-1-ide;platinum (PubChem CID 166053020) has the molecular formula C51H35N5OPt-2 and a molecular weight of 939.01 g/mol. Its IUPAC name is 9-[4-(azetidin-1-yl)-2-pyridinyl]-2-[3-[3-[2,6-bis(2,3,4,5,6-pentadeuteriophenyl)phenyl]-2H-benzimidazol-3-ium-2-id-1-yl]benzene-2-id-1-yl]oxy-1H-carbazol-1-ide;platinum.
| Compound Name | 9-[4-(azetidin-1-yl)-2-pyridinyl]-2-[3-[3-[2,6-bis(2,3,4,5,6-pentadeuteriophenyl)phenyl]-2H-benzimidazol-3-ium-2-id-1-yl]benzene-2-id-1-yl]oxy-1H-carbazol-1-ide;platinum |
|---|---|
| PubChem CID | 166053020 |
| Molecular Formula | C51H35N5OPt-2 |
| Molecular Weight | 939.01 g/mol |
| Exact Mass | 938.31 |
| IUPAC Name | 9-[4-(azetidin-1-yl)-2-pyridinyl]-2-[3-[3-[2,6-bis(2,3,4,5,6-pentadeuteriophenyl)phenyl]-2H-benzimidazol-3-ium-2-id-1-yl]benzene-2-id-1-yl]oxy-1H-carbazol-1-ide;platinum |
| SMILES | [2H]c1c([2H])c([2H])c(-c2cccc(-c3c([2H])c([2H])c([2H])c([2H])c3[2H])c2-[n+]2[c-]n(-c3[c-]c(Oc4[c-]c5c(cc4)c4ccccc4n5-c4cc(N5CCC5)ccn4)ccc3)c3ccccc32)c([2H])c1[2H].[Pt] |
| InChI | InChI=1S/C51H35N5O.Pt/c1-3-14-36(15-4-1)42-21-12-22-43(37-16-5-2-6-17-37)51(42)55-35-54(47-24-9-10-25-48(47)55)39-18-11-19-40(32-39)57-41-26-27-45-44-20-7-8-23-46(44)56(49(45)34-41)50-33-38(28-29-52-50)53-30-13-31-53;/h1-12,14-29,33H,13,30-31H2;/q-2;/i1D,2D,3D,4D,5D,6D,14D,15D,16D,17D; |
| InChIKey | BLHLLOPXLLMVTL-ZYGJMLDFSA-N |
| XLogP | 11.13 |
| TPSA | 39.10 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 58 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 939.01 |
| LogP ≤ 5 | 11.13 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
| Structural Alerts | {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|